| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |